Viatris (VTRS) just posted third quarter 2026 results that beat earnings expectations while revenue came in slightly light, and management raised full year guidance midpoints across key financial metrics, signaling confidence in ongoing operations. The earnings beat, raised guidance and confirmed dividend appear to have fed into a strong run in Viatris. The 30-day share price return of 14.16% and year-to-date share price gain of 59.79% build on a 1-year total shareholder return of 103.71%,...
Viatris stock topped its buy zone Thursday, shaking off light sales amid enthusiasm for its continued strength in China.
Viatris (VTRS) stock spiked after the company posted a Q3 2026 earnings beat but missed on revenue as generics sales slipped. Read more here.
VTRS heads into Q3 earnings with new product growth, regional sales trends and supply challenges shaping its outlook.
This is the newest page. Registered accounts read further back.